APA (7th ed.) Citation

Z, C., M, M., GS, M., M, N., T, F., E, U., . . . A, M. (2022). Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis. Circulation. Cardiovascular interventions, 15(9), e011693. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011693

Chicago Style (17th ed.) Citation

Z, Chen, et al. "Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis." Circulation. Cardiovascular Interventions 15, no. 9 (2022): e011693. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011693.

MLA (9th ed.) Citation

Z, Chen, et al. "Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis." Circulation. Cardiovascular Interventions, vol. 15, no. 9, 2022, p. e011693, https://doi.org/10.1161/CIRCINTERVENTIONS.121.011693.